CVS Health Corporation (CVS) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest CVS Health Corporation (CVS) short-term stock forecast for year 2025, month by month, and long-term CVS price prediction for years 2025 to 2050. Check CVS historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest CVS news and headlines.
1 Month Prediction
$130.23 [99.36%]
3 Month Prediction
$110.91 [69.79%]
6 Month Prediction
$108.50 [66.09%]
1 Year Prediction
$109.87 [68.18%]
3 Year Prediction
$76.93 [17.76%]
5 Year Prediction
$43.92 [-32.77%]
About CVS Health Corporation
CVS Health Corporation is an American healthcare company headquartered in Woonsocket, Rhode Island. The company was founded in 1963 in Lowell, Massachusetts, as Consumer Value Stores, but, now, it has grown into a major health solutions provider.
CVS Health operates through four main segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Their retail division, CVS Pharmacy, is one of the largest pharmacy chains in the United States, with over 9,100 locations. Also, CVS provides healthcare services through its MinuteClinic locations, offering more than 190 clinical services, including acute care, preventive care, chronic disease management, and mental health services.
CVS Health has over 300,000 workers, which includes 40,000+ doctors, pharmacists, and nurses. Also, They have mobile apps for easy access to services.
CVS Health Corporation (CVS) Historical Performance
IPO Date
CVS Health Corporation (NYSE:CVS) went public on 20 November, 1996.
Change
Since inception, CVS has increased by 3,198.45%. In the last 5 years, CVS has risen from $50.69 to $65.32, a massive 28.86% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $95.63 and a low of $44.33.
52 Week Range
$43.56
$80.75
The current price $65.33 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
CVS Stock Price History
Based on CVS stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the CVS stock has risen from $48.7 - $59.81 to $55.77 - $65.32, which is up 18.1%. Currently, the stock follows upward trend.
Here, we have calculated stock range of CVS, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $48.7 - $59.81 | $54.22 | 5.75 | 1 Year Change |
| 2021 | $60.06 - $92.63 | $73.79 | 43.92 | 2 Year Change |
| 2022 | $84.08 - $95.63 | $89.01 | 73.6 | 3 Year Change |
| 2023 | $61.24 - $81.0 | $68.59 | 33.78 | 4 Year Change |
| 2024 | $44.33 - $76.28 | $60.95 | 18.88 | 5 Year Change |
| 2025 | $55.77 - $65.32 | $60.55 | 18.1 | 6 Year Change |
CVS Price Performance
6-Month Performance
CVS stock jumped by 6.38% in the last six months.
1-Year Performance
The stock has trended downwards by 14.37% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 28.50%.
5-Year Performance
In the last 5 years, the stock has gone up by 28.86%.
According to CVS Health Corporation's historical data, below graph gives us the exact picture of how the CVS stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
5.14% ↓
2021
54.87% ↑
2022
7.63% ↓
2023
12.53% ↓
2024
40.77% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
CVS Health Corporation (CVS) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $95.43 B (Q3)
Revenue for Q3 ending 30th September, 2024 increased 4.60% compared to Q2 ending 30th June, 2024.
Annual Revenue: $368.91 B (1Y)
Revenue for trailing 12 months increased 3.11% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $268.71 billion to $368.91 billion, a 37.29% change.
Market Capitalization
CVS Health Corporation has a market capitalization of $82.36B, which places CVS in the large-cap category.
Fundamental Analysis
EPS: $0.07 (Q3), $6.49 (1Y)
EPS decreased 95.04% since last quarter, and increased 97.26% since last year.
Net Income: $87.00 M (Q3), $8.34 B (1Y)
Net Income decreased 95.08% since last quarter, and increased 93.55% since last year.
Free Cash Flow: $-1.42 B (Q3), $10.39 B (1Y)
Free Cash Flow decreased 157.73% since last quarter, and decreased 22.71% since last year.
Net Profit Margin: 0.09% (Q3), 2.26% (1Y)
Net Profit Margin decreased 95.30% since last quarter, and increased 87.71% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for CVS stock. These indicators help you understand CVS Health Corporation's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for CVS stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $55.71 |
| SMA50 | $51.35 |
| SMA200 | $55.74 |
| RSI | 79.58 |
| Beta | 0.54 |
SMA20 < Current Price
This signals CVS stock is in short-term bullish momentum.
SMA50 < Current Price
This signals CVS stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals CVS stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for CVS stock is Bullish. Out of all indicators, 5 indicates bullish signals, 3 signals bearish trends and 1 gives neutral trends. The CVS stock forecast was last updated on 17 February, 2025.
CVS Health Corporation (CVS) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $115.04 by the end of 2025, and can reach around $112.27 to $102.97 in 2026. And, the long-term forecast suggests that the stock may further drop to $83.76 - $63.68 in 2028, and $30.77 - $24.28 by 2031. So, the CVS stock shows a strong upward trend in the next several years.
Short-term CVS Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $130.23 | 99.36% |
| 2025-04 | $118.64 | 81.62% |
| 2025-05 | $110.91 | 69.78% |
| 2025-06 | $110.23 | 68.74% |
| 2025-07 | $111.56 | 70.78% |
| 2025-08 | $108.50 | 66.09% |
| 2025-09 | $108.90 | 66.7% |
| 2025-10 | $106.79 | 63.47% |
| 2025-11 | $105.46 | 61.44% |
| 2025-12 | $115.04 | 76.1% |
In 2025, the CVS stock price is expected to fluctuate between $105.46 and $130.23. According to the monthly forecast, the stock could rise to $115.04 by December 2024. If compared to the CVS's current price, the stock could gain 76.1% by the end of this year.
Long-term CVS Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $112.27 | $112.93 | $102.97 | 57.63% |
| 2027 | $90.92 | $72.04 | $82.96 | 27.0% |
| 2028 | $83.76 | $65.09 | $63.68 | -2.52% |
| 2029 | $79.54 | $57.13 | $54.16 | -17.09% |
| 2030 | $45.47 | $36.20 | $28.52 | -56.34% |
| 2031 | $30.77 | $22.37 | $24.28 | -62.83% |
| 2032 | $11.88 | $6.39 | $2.68 | -95.9% |
| 2033 | $1.16 | $1.08 | $0.89 | -98.64% |
| 2034 | $0.99 | $1.06 | $1.01 | -98.45% |
| 2035 | $1.01 | $0.97 | $1.02 | -98.44% |
| 2036 | $0.88 | $1.26 | $1.00 | -98.47% |
| 2037 | $0.92 | $0.96 | $1.14 | -98.25% |
| 2038 | $1.22 | $1.00 | $0.93 | -98.58% |
| 2039 | $1.25 | $0.90 | $0.82 | -98.74% |
| 2040 | $1.14 | $1.07 | $0.93 | -98.58% |
| 2041 | $0.85 | $1.14 | $1.00 | -98.47% |
| 2042 | $1.11 | $0.94 | $0.88 | -98.65% |
| 2043 | $1.00 | $1.00 | $1.14 | -98.25% |
| 2044 | $0.85 | $1.05 | $0.95 | -98.55% |
| 2045 | $0.98 | $0.85 | $0.95 | -98.55% |
| 2046 | $1.13 | $1.01 | $1.14 | -98.25% |
| 2047 | $1.03 | $0.89 | $0.92 | -98.59% |
| 2048 | $1.05 | $0.97 | $1.18 | -98.19% |
| 2049 | $0.96 | $1.07 | $1.06 | -98.38% |
| 2050 | $0.99 | $0.89 | $0.92 | -98.59% |
| 2051 | $0.87 | $1.03 | $1.08 | -98.35% |
CVS Health Corporation (CVS) Stock Price Prediction & Forecast 2025
At the start of 2025, the CVS stock was at $55.77. Today, it is trading at $65.32, which is 17.13% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $115.04 by December 2025 with a 76.10% change.
CVS Health Corporation (CVS) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the CVS stock. During this period, the CVS's price is forecasted to shift from $112.27 to $28.52, which is -74.60% loss.
In 2026, the stock would possibly open at $112.27, escalates to $112.93 by mid-year, and wraps up at $102.97, reflecting a 57.62% increase from today's price. Further moving to 2030, the stock can kick off the year at $45.47, soar to $36.20 by mid-year, and finish at $28.52, which is -56.34% change from current price.
CVS Health Corporation (CVS) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $30.77 to $0.93, which is down -62.83%
In 2031, we can expect CVS to fluctuate between $24.28 and $30.77, a shift indicating a -62.83% loss by year-end compared to current price. And Until 2040, CVS can likely vary from $0.93 to $1.14. By the end of 2040, the stock could record a -98.57% fall from today's stock price.
CVS Health Corporation (CVS) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the CVS stock can see an an upturn from $0.85 to $0.92 in this period. In 2041, the stock can experience a high of $1.14 by mid-year, closing the year at $1.00. This results in a -98.25% decrease from today.
Moving towards the end of 2050, CVS is projected to open the year at $0.99. The stock may dip to $0.89 during mid-year and finish the year at $0.92. Compared to the stock's current price, this translates to an overall loss of -98.59% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
CVS : Buy, Sell Or Hold?
Analyst Ratings
Based on 26 analysts, 7 rated as a strong buy, 12 recommended a buy, 7 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 26 analysts, 5 analysts gave a strong buy rating, 10 a buy rating, 11 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for CVS stock is Buy.
Expert Analysis
According to CVS short-term and long-term forecast, CVS Health Corporation shares are projected to go down by 98.59%, and reach a value of $0.92 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 71.42857142857143, which signals Greed. Also, CVS has recorded 15/30 green days, which reflects a 68.18181818181817% positivity rate with a price volatility of 0.03%.
Plus, Price-to-Earnings (P/E) ratio of 17.84836 suggests that CVS stock is overvalued. So, Based on CVS prediction and analysis, it may be the best time to hold CVS stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "CVS” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.